Evaluation of endothelial function in subclinical thyroid dysfunction [2]

Thyroid

Volumn 16, Issue 2, 2006, Pages 200-201

  Dardano, A ^a   Caraccio, N ^a   Monzani, F ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LEVOTHYROXINE; NITRIC OXIDE SYNTHASE; THYROID HORMONE;

ARTERY ENDOTHELIUM; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DYSLIPIDEMIA; EVALUATION; HUMAN; HYPOTHYROIDISM; LETTER; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; THYROID FUNCTION;

ARTERIOSCLEROSIS; CAROTID ARTERIES; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; RISK FACTORS; THYROID DISEASES; TUNICA INTIMA; TUNICA MEDIA; VASODILATION;

EID: 33645468946     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.200     Document Type: Letter

References (9)

1. Cikim AS, Oflaz H, Ozbev N, Cikim K, Umman S, Meric M, Sencer E, Molvalilar S 2004 Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism. Thyroid 14:605-609.
2. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ 2004 Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228-238.
3. Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe I, Huber P, Herzog R, Muller B 2001 TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial. J Clin Endocrinol Metab 86:4860-4866.
4. Caraccio N, Ferrannini E, Monzani F 2002 Lipoprotein profile in subclinical hypothyroidism: response to levothyroxinc replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 87:1533-1538.
5. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ 1995 Atherosclerosis: basic mechanism. Oxidation, inflammation, and genetics. Circulation 91:2488-2496.
6. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni E, Salvetti A, Ferrannini E, Monzani F 2003 Impaired endothelium-depcndent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88:3731-3737.
7. Monzani F, Caraccio N, Kozakowa M, Dardano A, Vittone F, Virdis A, Taddei S, Palombo C, Ferrannini E 2004 Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab 89:2099-2106.
8. th Edition, p. 2051.
9. Mizuma H, Murakami M, Mori M 2001 Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase. Circ Res 88:313-318.